ReadyTech Holdings (ASX:RDY) Total Current Liabilities : A$53.7 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is ReadyTech Holdings Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. ReadyTech Holdings's total current liabilities for the quarter that ended in Dec. 2023 was A$53.7

ReadyTech Holdings Total Current Liabilities Historical Data

The historical data trend for ReadyTech Holdings's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReadyTech Holdings Total Current Liabilities Chart

ReadyTech Holdings Annual Data

Trend Jun19 Jun20 Jun21 Jun22 Jun23

Total Current Liabilities

16.00 24.87 44.56 49.43 49.95

ReadyTech Holdings Semi-Annual Data

Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23

Total Current Liabilities Get a 7-Day Free Trial 41.85 49.43 50.33 49.95 53.66

ReadyTech Holdings Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

ReadyTech Holdings's Total Current Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Current Liabilities = Accounts Payable & Accrued Expense + Short-Term Debt & Capital Lease Obligation

= 11.767 + 1.229

+ Other Current Liabilities + Current Deferred Liabilities

= 36.954 + 0

= 50.0

ReadyTech Holdings's Total Current Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Current Liabilities = Accounts Payable & Accrued Expense + Short-Term Debt & Capital Lease Obligation

= 7.933 + 0.968

+ Other Current Liabilities + Current Deferred Liabilities

= 44.763 + 0

= 53.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

ReadyTech Holdings Total Current Liabilities Related Terms
Thank you for viewing the detailed overview of ReadyTech Holdings's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

ReadyTech Holdings (ASX:RDY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » ReadyTech Holdings Ltd (ASX:RDY) » Definitions » Total Current Liabilities

Comparable Companies

ASX:NXL ASX:RUL ASX:BVS ASX:IFM ASX:SYM ASX:C79 ASX:DSE ASX:BTH ASX:IOD ASX:TSK CRM XTER:SAP INTU NOW UBER CDNS SHOP WDAY XPAR:DSY ROP

Traded in Other Exchanges

N/A

Address

77 King Street, Level 2, Sydney, NSW, AUS, 2000

Website

https://www.readytech.com.au

ReadyTech Holdings Ltd is a provider of people management software for educators, employers, and facilitators of career transitions. Its products are JR Plus, A2E, HR3, ePayroll, JR Gov, Aussiepay, and others. The company's operating segments include Education and Work pathways, Workforce Solutions, and Government and Justice. It generates maximum revenue from the Education segment. The education segment mainly provides products and services to tertiary education providers. Its Workforce segment provides products and services to a mid-sized company across various industries. The Government division provides government and justice case management software as a service solution to local governments, state governments and justice departments.

ReadyTech Holdings (ASX:RDY) Headlines

From GuruFocus

Dr. Reddy's Announces the First-to-Market Launch of Over-the-Counter, Store-Brand Equivalent of Allegra-D� 24 Hr in the U.S. Market
By Business Wire Business Wire • 07-22-2022

Dr. Reddy's Laboratories Announces the Launch of Pemetrexed for Injection USP, in the U.S. Market
By Business Wire Business Wire • 05-27-2022

Aurigene Discovery Technologies Limited Announces Drug Discovery, Development and Commercialization Partnership with EQRx
By Business Wire Business Wire • 07-05-2022

Dr. Reddy's Successfully Completes Phase I Study (IV Route) of DRL_TC, a Proposed Biosimilar of Tocilizumab
By Business Wire Business Wire • 06-05-2023

Dr. Reddy's Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany
By Business Wire Business Wire • 04-01-2022

Dr. Reddy's Laboratories Announces its Launch of Saxagliptin and Metformin Hydrochloride Extended-Release Tablets in the U.S.
By Business Wire • 08-10-2023

Dr. Reddy's Announces the Acquisition of MenoLabs�, a Leading Women's Health and Dietary Supplements Portfolio of Brands
By Business Wire • 01-03-2024

Dr. Reddy's Successfully Completes Phase 1 Study of DRL_TC, a Proposed Biosimilar of Tocilizumab
By Business Wire Business Wire • 12-19-2022

Dr. Reddy's Laboratories Announces the Launch of Its Authorized Generic Version of VASOSTRICT� (vasopressin injection, USP) Vials in the U.S. Market
By Business Wire Business Wire • 02-09-2022

Dr. Reddy's Proposed Rituximab Biosimilar Application Accepted for Review by USFDA, EMA and MHRA
By Business Wire • 07-12-2023

ReadyTech Holdings Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Current Liabilities	Get a 7-Day Free Trial						41.85	49.43	50.33	49.95	53.66

Total Current Liabilities	=	Accounts Payable & Accrued Expense	+	Short-Term Debt & Capital Lease Obligation
	=	11.767	+	1.229
	+	Other Current Liabilities	+	Current Deferred Liabilities
	=	36.954	+	0
	=	50.0